Author:
Daumas-Duport B.,Auffray-Calvier E.,Guillon B.,Gilly A. de Kersaint,Desal H.-A.
Reference71 articles.
1. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group;N. Engl. J. Med.,1995
2. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators;Hacke;Lancet,1998
3. Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations;Hankey;Lancet,1999
4. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study);Rothwell;Lancet,2005
5. Organised inpatient (stroke unit) care for stroke. Stroke Unit Trialists' Collaboration;Cochrane Database Syst Rev,2000